Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.510
+0.160 (6.81%)
At close: May 12, 2025, 4:00 PM
2.510
0.00 (0.00%)
After-hours: May 12, 2025, 8:00 PM EDT
CATX's stock price has decreased by -85.66% in the past year and price targets may not have had time to catch up.
Perspective Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$13.89
Upside
+453.39%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $21 → $10 | Strong Buy | Maintains | $21 → $10 | +298.41% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +298.41% | Mar 31, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $16 → $15 | Buy | Maintains | $16 → $15 | +497.61% | Mar 27, 2025 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +338.25% | Mar 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +298.41% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +298.41% | Mar 13, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $15 | Buy | Initiates | $15 | +497.61% | Mar 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $16 | Buy | Reiterates | $16 | +537.45% | Jan 14, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $25 → $16 | Buy | Maintains | $25 → $16 | +537.45% | Nov 25, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $24 → $6 | Strong Buy → Hold | Downgrades | $24 → $6 | +139.04% | Nov 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $22 → $16 | Buy | Maintains | $22 → $16 | +537.45% | Nov 22, 2024 |
| Wedbush | Wedbush | Buy Reiterates $20 | Buy | Reiterates | $20 | +696.81% | Oct 24, 2024 |
| UBS | UBS | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +696.81% | Oct 24, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $22 | Buy | Reiterates | $22 | +776.49% | Oct 11, 2024 |
| Wedbush | Wedbush | Buy Initiates $25 | Buy | Initiates | $25 | +896.02% | Oct 1, 2024 |
| Truist Securities | Truist Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +736.65% | Sep 25, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.